Retainer paid to an agency to post 3 Instagram reels a week: ₹50,000/month.
Fee offered to a CA to verify ₹20 Crore turnover and assume statutory liability in Form 3CD: ₹15,000 one-time.
One makes short videos. The other signs a legal document that can land them in front of NFRA.
The market doesn't underpay CAs because the work lacks value. It underpays them because too many CAs price their statutory signature like data entry.
Sorry to interrupt your Sunday, friends.
I really hesitated to write this, but if I don’t speak up today, I will be facing a severe financial crisis within a week or two.
To be clear, I am not asking for charity or financial help. I am asking for work.
I have been completely without work for the last three months. My last project ended on June 30th, and since then I have knocked on every door I know—calling, texting, meeting contacts, and following up.
People say they will try, but after that first talk, the silence takes over. Calls go unanswered or get cut after a couple of rings. I honestly don't know whether the industry is shifting because of AI or if my age (52) is working against me, but despite over 13 years of solid experience in the field, nothing has materialized.
Now, my savings are down to the very end. I can barely hold out for another week or two.
I am a professional content writer, translator, and speaker who is comfortable on stage and in front of the camera. I write and translate fluently across Gujarati, Hindi, and English, with Gujarati being my strongest suit.
Many of you already know my grasp of politics and my political writing, but I am equally adept at covering Bollywood and cricket. My priority is media houses, digital platforms, or publications, but I am open to any genuine writing or translation opportunity.
I can work remotely or take up assignments on-site anywhere in Ahmedabad and Gandhinagar, as I need to be close to my elderly mother to take care of her health.
Because my situation is urgent, I am especially looking for quick-turnaround freelance assignments or immediate projects where payments can be settled on submission.
If you or anyone in your circle has work, please reach out to me directly in my DMs.
A humble, earnest request: while I deeply value your warmth, please refrain from sending just "best wishes" or "stay strong" messages right now. I am fighting hard to stay out of a very dark headspace, and right now, only actual work leads can pull me through.
Thank you for taking the time to read this, and thank you for your support. My inbox is open. 🙏
राष्ट्रवादी टॅक्स प्रॅक्टिशनर सेल शरदचंद्र पवार पक्षाचे महाराष्ट्र राज्यप्रमुख श्री. नागेश साळुंखे यांनी करदाते व Tax Professionals यांना भेडसावणाऱ्या अडचणींबाबत भेट घेऊन निवेदन दिले. आयकर विवरणपत्रांसाठी 31 जुलै आणि 31ऑगस्ट या अंतिम मुदतीनंतर कर लेखापरीक्षणासाठी 30 सप्टेंबरची मुदत अपुरी पडत असल्याचे निवेदनात नमूद करण्यात आले आहे.
कर निर्धारण वर्ष २०२६-२७ साठी कर लेखापरीक्षण अहवाल सादर करण्याची अंतिम मुदत ३० सप्टेंबर आहे. जीएसटी आणि टीडीएसशी संबंधित कामांचा ताण, प्राप्तिकर पोर्टलवरील तांत्रिक अडचणी, नुकतेच झालेले सण आणि २८ ते ३० सप्टेंबरदरम्यान प्रस्तावित देशव्यापी बँक संप यांमुळे सनदी लेखापाल, कर सल्लागार आणि करदात्यांना काम पूर्ण करताना अडचणी येत आहेत.
लेखापरीक्षणाचे काम अचूक आणि परिपूर्ण व्हावे, यासाठी अहवाल सादर करण्याची मुदत वाढवण्याची मागणी होत आहे.
केंद्रीय अर्थमंत्री मा. निर्मला सीतारामन जी यांनी या व्यावहारिक अडचणींचा सहानुभूतीपूर्वक विचार करून कर लेखापरीक्षण अहवाल सादर करण्याची तसेच संबंधित प्राप्तिकर विवरणपत्रे भरण्याची मुदत वाढवावी, ही विनंती. यामुळे करदात्यांना मोठा दिलासा मिळेल.
I received a representation from Shri Nagesh Salunkhe, State Head of the @NCPspeaks Tax Practitioners Cell, Maharashtra, highlighting the difficulties faced by taxpayers and tax professionals in completing tax audits within the current deadline. With the income tax return deadlines of 31 July and 31 August having already passed, the time available until 30 September is considered inadequate for completing tax audits that involve detailed verification, scrutiny and reconciliation.
For Assessment Year 2026-27, tax audit reports are due on 30 September. Chartered accountants, tax consultants and taxpayers are under pressure due to GST and TDS work, difficulties with the income tax portal, recent festivals and the proposed nationwide bank strike from 28 to 30 September.
I urge Hon. Nirmala Sitharaman Ji to extend the deadline for submitting tax audit reports, along with the corresponding deadline for filing income tax returns in audit cases. This would provide much-needed relief to taxpayers and allow the work to be completed accurately.
@nsitharaman@nsitharamanoffc@FinMinIndia
I’m convinced that the ability to remain unshaken by the minor inconveniences of life puts you ahead of 95% of people. Emotional control is the ultimate power. Few have it. Not every collision or slight deserves your energy. You can just let them float by.
When incentives are placed in the right place, the entire ecosystem grows. Consumers, distributors and firms.
Much delayed reform in insurance is finally happening.
This is not an easy shift and here is hoping that IRDAI does not blink.
Why you want audit deadline extension?
You want to do better work at audit of accounts?
Look at the work they are doing with highways.
Just 7 days it should work good. They doesn’t care if it collapses on 8th day.
Same quality they want with accounts.
You stupid people. You want extension?
o Instagram LEVOU AS PESSOAS a acreditarem que um relacionamento se resume a viagens, jantares em restaurantes, e experiências incríveis. Mas um relacionamento se constrói no dia a dia, na vida doméstica, no cansaço, no tédio
India's cash market has a liquidity problem. And STT is a big part of it.
I ran a simple number-crunch this week: how many times does a country's tradable stock float actually change hands?
Method:
Market cap × free float % = free float value
Average daily cash turnover ÷ free float value = daily turnover velocity
The results:
🇮🇳 India: ₹474 lakh cr market cap, ~50% free float, ₹1.13 lakh cr daily cash turnover
→ 0.48% of free float trades per day. About 1.2x a year.
🇺🇸 US: $75 trn market cap, ~90% float, $1.1 trn daily
→ ~1.6% per day. About 4x a year.
🇨🇳 China: ¥117 trn market cap, ~65% float, ¥2.7 trn daily
→ ~3.6% per day. About 9x a year.
China's float turns over 7–8x faster than ours. The US turns over 3–4x faster.
Why it matters:
Low turnover means thin order books, wider spreads, higher impact cost, and weaker price discovery, especially outside the top 200 stocks. A large investor can't enter or exit without moving the price. That's a microstructure problem, not just a volume problem.
The cost gap:
A delivery trade in India pays 0.1% STT on each side, so 0.2% per round trip before brokerage and other charges. China charges 0.05% stamp duty, on the sell side only. The US has no transaction tax, only a negligible regulatory fee. In fact US allows darkpools.
When the friction is 4x China's and near-infinite versus the US, capital does the rational thing. It avoids the cash market and moves to F&O, where the tax per rupee of exposure is lower. We've built a tax structure that pushes speculation into derivatives and starves the cash market of depth.
Deep cash markets make healthy capital markets. If we want India to be a $10 trn market, liquidity in the underlying has to be priced right.
Time to rethink STT.
#StockMarket #India #STT #MarketMicrostructure #Liquidity
Extend TAR Due Date🚨
Tax Auditors should ideally be applying auditing skills, professional judgement & due diligence during Audits
Instead,they are forced to work with an impractical deadline constantly on their minds
Not good for auditors, assesses & Tax ecosystem as a whole!!
#ExtendDuedate @IncomeTaxIndia@FinMinIndia
Dear Dr.,
Please don’t give arguments just for the sake of defending private hospitals.
A hospital is NOT a 5-star hotel.
It is a place where people go when they are sick and vulnerable.
Yes, private hospitals provide better services than many government hospitals
And they should absolutely charge for quality healthcare.
But the real question is:
HOW MUCH IS TOO MUCH?
Hospitals already benefit from various government concessions, including subsidised land and other incentives.
And the numbers are staggering.
The top 10 hospital companies reported around ₹11,580 crore in profits in FY26.
Profitability itself isn’t the problem.
What concerns me is the limit on what hospitals can charge patients.
In the name of “private healthcare”,
If hospitals can keep increasing prices for procedures, consumables, rooms and other services without meaningful checks,
the patient ultimately pays.
And that contributes to rising healthcare costs and medical inflation.
At ~14% medical inflation,
The cost of hospitalisation can double in roughly 5 years.
Even Parliament has raised concerns around pricing practices in private hospitals.
So instead of endlessly arguing about whether private hospitals are justified…
The bigger question is:
How can the government, private hospitals and insurance companies work together to build a healthcare system that is:
✅ Affordable
✅ Sustainable
✅ High quality
✅ Accessible to everyone
Private healthcare has an important role to play.
But affordability cannot be ignored.
Measuring your progress against others is a sure fire path to constant disappointment. Measure your progress against where you started, where you’ve been, where you were yesterday. It’s far more rewarding and informative to evaluate yourself against yourself.
The most expensive part of a hospital bill may never touch the hospital at all.
A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue.
A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310.
These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it.
The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored.
A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone.
#PublicHealth #GoodGovernance #Leadership #TukaramMundhe
https://t.co/Ye9CVzr8qU
Absolutely do not do this.
This is mostly offered by "Cosmetologists" or commercialized Dermatology clinic chains. Cosmetology is not a recognized medical degree or a protected medical title under the National Medical Commission in India. So anyone claiming to be "cosmetologist" is not really a medical practitioner. They are similar to certified "coaches" or "wellness experts".
The clinical evidence supporting IV glutathione is exceptionally poor. Marketing claims rely heavily on anecdotal reports and a single, widely criticized trial that suffered from a tiny sample size, poor study design, and unreliable evaluations.
Because the body continuously produces melanin, any potential lightening effect is temporary. Once the extreme systemic doses are stopped, the skin's natural pigmentation returns.
Because IV glutathione is not approved for cosmetic use, the solutions utilized in wellness clinics and med-spas are typically sourced from "compounding pharmacies". This bypasses standard pharmaceutical manufacturing regulations, introducing severe risks.
A "compounded drug" is a custom medication created by a pharmacist or physician who combines, mixes, or alters ingredients on their own.
In August 2026, the US FDA issued an urgent safety warning after dozens of patients experienced potentially fatal infection (sepsis)-like symptoms - including fever, chills, low blood pressure, and hospitalization, following glutathione IV treatments. Clinics were found to be compounding IV drips using dietary-supplement-grade powder, which contained dangerously high levels of bacterial endotoxins.
Administering high doses has been linked to severe adverse effects, including anaphylaxis, acute kidney and liver dysfunction, and potentially fatal skin reactions like Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS and TEN)
Ultimately, the administration of IV glutathione in dermatology and cosmetology clinics is a lucrative marketing trend that operates outside the bounds of evidence-based medicine.
Like I said, absolutely, do not do this.
This statement given by you against the entire CA Community is not only wrong, prejudice but without knowing true facts.
Role of CAs in Nation Building has completely been ignored by you.
You should take this statement back immediately and tender an apology for defaming the whole community.
₹43 Crore Liquidation Sale: Should TDS Be Deducted First?
A company's assets were sold during liquidation for ₹43 crore. The purchaser deducted 1% TDS under Section 194-IA, amounting to ₹43 lakh.
The Liquidator argued that this effectively gave Income Tax priority over other creditors, while Section 53 of the IBC places government dues lower in the distribution waterfall.
The NCLAT agreed and held that Section 53 of the IBC overrides Section 194-IA in this situation, directing the Income Tax Department to refund the TDS.
A thread ( 1/n )